ZIMLAB
Zim Laboratories Limited
Pharmaceuticals
Share price
₹139
Market cap
₹743 Cr
1Y return
▲ 94%
A pharmaceutical manufacturer established in 1989, Zim Laboratories specializes in producing formulation drugs and pre-formulation ingredients for both domestic and international markets. The company operates manufacturing facilities across India with capabilities in drug development, quality assurance, and distribution. It serves healthcare providers and patients through a diversified portfolio of therapeutic formulations marketed within India and exported to markets worldwide.
Investors holding Zim Laboratories Limited
1.07%
Recent moves 2
Tata Mutual FundNew position
Tata Mutual Fund acquired a new position of 571,629 shares, a 1.07% stake, in Zim Laboratories. The stake is worth ₹6.91 Cr based on the last closing share price of ₹121.00.
Read more
Mathew CyriacIncreased
Mathew Cyriac increased his stake in Zim Laboratories from 11.84% to 19.34%, acquiring 40,12,702 shares for ₹26.69 Cr at ₹66.51 apiece through an open market purchase. This transaction crossed the 5% disclosure threshold.
Read more
Track the whales in Zim Laboratories Limited
Get alerted the moment a top investor buys or sells.
Get started